Zevra Therapeutics (ZVRA) EBITDA Margin (2019 - 2026)
Zevra Therapeutics (ZVRA) recorded EBITDA Margin of 31.63% in Q3 2026, up 14.26 percentage points from 17.38% a year earlier but down 11.54 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBITDA Margin (2019 - 2026) Analysis & Trends
On a TTM basis, Zevra Therapeutics' EBITDA Margin came in at 61.73% as of Sep 30, 2026, up 159.27 percentage points year-over-year; for FY2025, it was -55.29%, up 286.12 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -32.48 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -341.41% in FY2024 (-164.44 pp), -176.97% in FY2023 (+232.64 pp), -409.62% in FY2022 (-438.01 pp) and 28.40% in FY2021 (+51.21 pp).
- Quarterly EBITDA Margin has ranged from -1891.23% in Q2 2022 to 144.99% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for seven consecutive quarters, with an average year-over-year change of +263.24 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 1818.34 percentage points in Q2 2023, against a drop of 1940.43 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 43.18% (Q2 2026), 144.99% (Q1 2026) and 28.33% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 31.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 31.63% |
| Jun 30, 2026 | 43.18% |
| Mar 31, 2026 | 144.99% |
| Dec 31, 2025 | 28.33% |
| Sep 30, 2025 | 17.38% |
| Jun 30, 2025 | -267.91% |
| Mar 31, 2025 | -18.20% |
| Dec 31, 2024 | -114.62% |
| Sep 30, 2024 | -694.30% |
| Jun 30, 2024 | -499.73% |
| Mar 31, 2024 | -552.53% |
| Dec 31, 2023 | -111.22% |
| Sep 30, 2023 | -528.57% |
| Jun 30, 2023 | -72.89% |
| Mar 31, 2023 | -401.51% |
| Dec 31, 2022 | -445.75% |
| Sep 30, 2022 | -216.70% |
| Jun 30, 2022 | -1,891.23% |
| Mar 31, 2022 | -45.25% |
| Dec 31, 2021 | -107.59% |
API Access
Zevra Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();